drugset / Trial / NCT00423449
Clinical Trial of MK0683 in Combination With FDA Approved Cancer Drugs in Patients With Advanced NSCLC (MK0683-058)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is a clinical trial to determine the safety and tolerability of MK0683 in combination with gemcitabine and cisplatin and/or carboplatin.
Timeline
- Start
- 2007-03
- Primary completion
- 2010-04
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | — |
| Subject | Cisplatin | Other / unclassified | 75 mg/m2 | Intravenous |
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | — |
| Subject | Gemcitabine | Small molecule | 1250 mg/m2 | — |
| Subject | Vorinostat | Small molecule | 300 mg | — |
| Subject | Vorinostat | Small molecule | 500 mg | — |